Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Herpes simplex Infection

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 9 articles:
HTML format



Single Articles


    August 2021
  1. GORANDER S, Honda-Okubo Y, Backstrom M, Baldwin J, et al
    A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01098.
    PubMed     Abstract available


    April 2021
  2. CARR DJJ, Berube AN, Filiberti A, Gmyrek GB, et al
    Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0DeltaNLS vaccine against ocular HSV-1 challenge.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00379.
    PubMed     Abstract available


    October 2020
  3. LATOURETTE PC 2ND, Awasthi S, Desmond A, Pardi N, et al
    Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31261.
    PubMed     Abstract available


    October 2019
  4. BERNSTEIN DI, Morello CS, Cardin RD, Bravo FJ, et al
    A vaccine containing highly purified virus particles in adjuvant provides high level protection against genital infection and disease in guinea pigs challenged intravaginally with homologous and heterologous strains of herpes simplex virus type 2.
    Vaccine. 2019 Oct 11. pii: S0264-410X(19)31332.
    PubMed     Abstract available


    September 2019
  5. BERNSTEIN DI, Cardin RD, Bravo FJ, Hamouda T, et al
    Intranasal nanoemulsion-adjuvanted HSV-2 subunit vaccine is effective as a prophylactic and therapeutic vaccine using the guinea pig model of genital herpes.
    Vaccine. 2019 Sep 9. pii: S0264-410X(19)31153.
    PubMed     Abstract available


    May 2019
  6. AWASTHI S, Hook LM, Swaminathan G, Cairns TM, et al
    Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants.
    Vaccine. 2019 May 29. pii: S0264-410X(19)30705.
    PubMed     Abstract available


  7. BERNSTEIN DI, Flechtner JB, McNeil LK, Heineman T, et al
    Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease.
    Vaccine. 2019 May 15. pii: S0264-410X(19)30621.
    PubMed     Abstract available


    April 2018
  8. SPICKNALL IH, Looker KJ, Gottlieb SL, Chesson HW, et al
    Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.
    Vaccine. 2018 Apr 3. pii: S0264-410X(18)30254.
    PubMed     Abstract available


    September 2017
  9. SCHIFFER JT, Gottlieb SL
    Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development.
    Vaccine. 2017 Sep 25. pii: S0264-410X(17)31273.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Herpes simplex Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: